Cynthia Collins
Human Longevity has appointed Cynthia Collins as CEO. She replaces Craig Venter, who will remain at the company and serve as executive chairman of the board of directors. Collins comes to HLI from GE Healthcare, where she served as CEO and general manager for Cell Therapy and Purification and ANalysis Businesses. Before that she served as CEO of GE's Clarient Diagnostics. She has also held various executive positions at Genvec, Cellular Analysis Business Group, Sequoia Pharmaceuticals, and Clinical Microsensors (now Genmark).